Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer-Reference-Cited by-同舟云学术

Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer

Published:2023-06 Issue: Volume:564 Page:216205
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lu Jiaye,Li Jingwei,Lin Ziyou,Li Huaxuan,Lou Linlin,Ding Wen,Ouyang Shumin,Wu Yonghui,Wen Yuanzhen,Chen Xiaobing,Yue Peibin,Wang Yuanxiang,Liu Peiqing,Lu Jinjian,Zhang Jian,Feng Weineng,Zhang Xiaolei^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Lung cancer 2020: epidemiology, etiology, and prevention;Bade;Clin. Chest Med.,2020

2. Lung cancer in China: current and prospect;Wu;Curr. Opin. Oncol.,2021

3. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet (London, England),2017

4. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3;Shou;Cancer Lett.,2016

5. Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues;Gridelli;Lung Cancer,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer;Molecular Cancer;2024-09-13

2. Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies;Frontiers in Pharmacology;2024-09-02

3. A pH transformable nanocarrier for gradual and precise delivery of a natural immunomodulator and chemotherapy agent to trigger tumor apoptosis;Chemical Engineering Journal;2024-09

4. Shaping the immune landscape: Multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration;Heliyon;2024-09

5. The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways;Cell Communication and Signaling;2024-08-19